Biozoom, Inc. BIZM Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Biozoom, Inc. BIZM Company Overview 

Stock Message Board http://investorshangout.com/search?q=BIZM&...mp;yt1=Go!

Biozoom, Inc. BIZM Current Price and Quotes



Biozoom, Inc. BIZM
Company Information
Wilhelmshoeher Allee 273A
Kassel 34131
Germany

Website: http://www.biozoom.net
Phone: 800-882-1683
Email: info@biozoom.net

Biozoom, Inc. BIZM
Biozoom is dedicated to the advancement of reflection spectroscopy as a commercial technology. Today's Biozoom technology can be used by anyone, anywhere, as a health and wellness diagnostic tool. The company is constantly researching new applications and innovations.

Biozoom, Inc. BIZM
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Latest Report Jun 30, 2013 10-Q
CIK 0001438576
Fiscal Year End 3/31
OTC Marketplace Grey Market
Profile Data
SIC - Industry Classification 3100 - Leather & Leather Products
Incorporated In: NV, USA
Year of Inc. 2007
Employees Not Available
Company Officers/Contacts
Hardy Hoheisel CEO
Tefa Dexter Secretary
Wolfgang Koecher CTO
Company Directors
Not Available
Company Notes
Formerly=Entertainment Art, Inc. until 4-2013
Service Providers
Auditor/Accountant
ZS Consulting Group, LLP
115 Broad Hollow Road
Suite 350
Melville, NY, 11747
United States

Legal Counsel
Brunson, Chandler & Jones, PLLC
175 South Main St.
Salt Lake City, UT, 84111
United States

Investor Relations Firm
Not Available

Biozoom, Inc. BIZM
BIZM Security Details
Share Structure
Market Value1 $22,697,400 a/o Sep 04, 2013
Shares Outstanding 59,730,000 a/o Mar 22, 2013
Float 20,130,000 a/o Mar 22, 2013
Authorized Shares 100,000,000 a/o Mar 22, 2013
Par Value  0.001
Shareholders
Shareholders of Record 26 a/o Jun 19, 2012
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.00) Jul 22, 2009 Jul 08, 2009 Jul 21, 2009
Security Notes
Note=Trading temporarily suspended by the SEC pursuant to Section 12(k) of the Securities and Exchange Act of 1934 from 9:30 AM EST on 06/25/2013 through 11:59 PM EST on 07/09/2013.
Capital Change=shs increased by 33 for 1 split. Ex-date=07/22/2009. Rec date=07/08/2009. Pay date=07/21/2009.
Short Selling Data
Short Interest 198,413 (-9.1%)
Aug 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Manhattan Transfer Registrar Co.

Biozoom, Inc. BIZM Recent News


Jul 23, 2013 CRWEPRESSRELEASE Daily Stock Watch Biozoom (OTCQB:BIZM), Mercari Communications Group, Ltd. (OTCQB:MCAR), and Crown Equity Holdings, Inc. (OTCQB:CRWE)
Jul 11, 2013 BIZM, ARTH, AAMRQ and SGLB added to Active OTC Watch List at EPR
Jun 25, 2013 BIZM, NORX, ACCS and MJNA added to Active OTC Watch List at EPR
Jun 24, 2013 Biozoom Enters Into Commercial Phase of Scanner Production
Jun 19, 2013 Biozoom's Advanced Nanospectroscopy Based On Licensable, Cutting-Edge Intellectual Property With Many Possible Applications
Jun 19, 2013 OTC Daily Alert Stock Watch
Jun 17, 2013 University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work
Jun 17, 2013 BIZM, NORX, XUII and LOTED added to Active OTC Watch List at EPR
Jun 14, 2013 Biozoom Exercises Purchase Option Under Joint Venture Agreement With Spectroscopic Technology Developer, Opsolution
Jun 12, 2013 Biozoom Launches Sales & Business Development Office In Strategic Southern California Location

12next >

Biozoom, Inc. BIZM Financials
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue - - - 2
Cost of Revenue - - - 2
Gross Profit - - - -
Operating Expenses
Research and Development 100 - - -
Sales, General and Admin. 124 26 25 33
Non-Recurring Items - - - -
Other - - - -
Operating Income (224) (26) (25) (33)
Income From Continuing Operations
Add'l Income/Expense Items 89 32 - 6
Earnings Before Interest and Tax (224) (26) (25) (27)
Interest Expense 1 5 5 3
Earnings Before Tax (225) (31) (30) (30)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (137) 1 (30) (24)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (137) 1 (30) (30)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (137) 1 (30) (30)

BIZM Biozoom, Inc. Research DD Guide

BIZM Biozoom, Inc. Stock Message Board http://investorshangout.com/search?q=BIZM&...mp;yt0=Go!
BIZM Biozoom, Inc. Stock Quote http://www.otcmarkets.com/stock/BIZM/quote
BIZM Biozoom, Inc. Stock Chart http://www.otcmarkets.com/stock/BIZM/chart
BIZM Biozoom, Inc. Company Info http://www.otcmarkets.com/stock/BIZM/company-info
BIZM Biozoom, Inc. Recent News http://www.otcmarkets.com/stock/BIZM/news
BIZM Biozoom, Inc. Financials http://www.otcmarkets.com/stock/BIZM/financials
BIZM Biozoom, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/BIZM/filings
BIZM Biozoom, Inc. Short Sales http://www.otcmarkets.com/stock/BIZM/short-sales
BIZM Biozoom, Inc. Insider Disclosure http://www.otcmarkets.com/stock/BIZM/insider-transactions
BIZM Biozoom, Inc. Research Reports http://www.otcmarkets.com/stock/BIZM/research
BIZM Biozoom, Inc. Summary http://finance.yahoo.com/q?s=BIZM
BIZM Biozoom, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=BIZM+Historical+Prices
BIZM Biozoom, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=BIZM
BIZM Biozoom, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=BIZM+Basic+Chart
BIZM Biozoom, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIZM+Basic+Tech.+Analysis
BIZM Biozoom, Inc. Headlines http://finance.yahoo.com/q/h?s=BIZM+Headlines
BIZM Biozoom, Inc. Press Releases http://finance.yahoo.com/q/p?s=BIZM+Press+Releases
BIZM Biozoom, Inc. Company Profile http://finance.yahoo.com/q/pr?s=BIZM+Profile
BIZM Biozoom, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=BIZM+Key+Statistics
BIZM Biozoom, Inc. Industry http://finance.yahoo.com/q/in?s=BIZM+Industry
BIZM Biozoom, Inc. Major Holders http://finance.yahoo.com/q/mh?s=BIZM+Major+Holders
BIZM Biozoom, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=BIZM+Insider+Transactions
BIZM Biozoom, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=BIZM+Insider+Roster
BIZM Biozoom, Inc. Income Statement http://finance.yahoo.com/q/is?s=BIZM
BIZM Biozoom, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=BIZM
BIZM Biozoom, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=BIZM+Cash+Flow&annual
BIZM Biozoom, Inc. Nasdaq http://www.nasdaq.com/symbol/BIZM
BIZM Biozoom, Inc. Market Watch http://www.marketwatch.com/investing/stock/BIZM
BIZM Biozoom, Inc. Bloomberg http://www.bloomberg.com/quote/BIZM:US
BIZM Biozoom, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=BIZM
BIZM Biozoom, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=BIZM
BIZM Biozoom, Inc. Barchart http://www.barchart.com/quotes/stocks/BIZM
BIZM Biozoom, Inc. OTC Short Report http://otcshortreport.com/index.php?index=BIZM
BIZM Biozoom, Inc. Investopedia http://www.investopedia.com/markets/stocks/BIZM/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading